Oura becomes latest US IPO hopeful to delay listing as market jitters deepen
TurnOnGreen updates bylaws to revise company name and meeting provisions
U.S.-China rivalry risks ‘over-securitization of almost everything,’ says Chinese strategist
Why is Hengrui Pharmaceuticals stock rallying today?
Taxpayer-funded pro-Trump ads violate laws against ‘publicity and propaganda,’ legal experts say
Latest articles
Popular articles
Featured
Newsletter
Subscribe to get the latest news, offers and special announcements.


